XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock-Based Compensation and Stockholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2021
Equity [Abstract] |
Stock-Based Compensation and Stockholders' Equity | Stock-Based Compensation and Stockholders' Equity Stock Options During the six months ended June 30, 2021, the Company issued an aggregate of 239,275 shares of common stock to employees upon the exercise of options previously granted under the 2016 Stock Incentive Plan at exercise prices ranging from $3.68 to $13.82 per share. Stock-based compensation expense (benefit) recognized for stock option awards was $1.6 million and $3.2 million during the three and six months ended June 30, 2021, respectivel y, compared to $0.6 million and $(5.5) million recognized during the three and six months ended June 30, 2020, respectively. Employee Stock Purchase Plan The 2021 Employee Stock Purchase Plan (“ESPP”) was approved by the Company's board of directors on September 10, 2020 and became effective on September 23, 2020. Under the ESPP, eligible employees may purchase a limited number of shares of our common stock at the lesser of 85% of the market value at the beginning of the offering period or 85% of the market value at the end of the offering period. The ESPP is intended to enable eligible employees to use payroll deductions to purchase shares of stock in offerings under the plan, and thereby acquire an interest in the Company. The maximum aggregate number of shares of stock available for purchase under the plan by eligible employees is 2,000,000 shares. 149,865 shares were issued through the ESPP during the three and six months ended June 30, 2021. The stock-based compensation expense recognized for the ESPP was $0.4 million and $0.7 million during the three and six months ended June 30, 2021, respectively. Stock-Based Compensation Expense The following table sets forth stock-based compensation expense (benefit), including the effects of gains and losses from changes in fair value during the three and six months ended June 30, 2020, recognized by the Company in the following line items in the Company's condensed consolidated statements of operations during the periods presented (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Cost of services | $ | 83 |  |  | $ | 70 |  |  | $ | 164 |  |  | $ | (246) |
Sales and marketing | 794 |  |  | 213 |  |  | 1,626 |  |  | (319) |
General and administrative | 1,044 |  |  | 297 |  |  | 2,102 |  |  | (4,919) |
Stock-based compensation expense (benefit) | $ | 1,921 |  |  | $ | 580 |  |  | $ | 3,892 |  |  | $ | (5,484) |
Stock Warrants As of June 30, 2021 and December 31, 2020, the Company had 9.4 million and 10.5 million fully vested outstanding warrants, respectively. As of June 30, 2021 and December 31, 2020, the holders of such warrants are entitled to purchase, in the aggregate, up to 5.2 million and 5.8 million shares, respectively, of common stock. Warrants can be exercised at a strike price of $24.39 per common share. The warrants were issued in 2016 upon the Company's emergence from its pre-packaged bankruptcy. During the three and six months ended June 30, 2021, 1,011,224 and 1,011,424 warrants, respectively, were exercised. No warrants were exercised during the three and six months ended June 30, 2020. These warrants expire on August 15, 2023. The $13.7 million proceeds received on the exercise of the warrants is recorded in Other in Cash flows from financing activities on the Company's condensed consolidated statement of cash flows. Share Repurchases On January 28, 2020, the Company repurchased approximately 1.0 million shares of its outstanding common stock from a single stockholder for a total purchase price of $12.6 million. On March 10, 2020, the Company repurchased approximately 0.8 million shares of its outstanding common stock, for a total purchase price of $9.2 million. During June 2020, the Company repurchased approximately 0.8 million of shares of its outstanding common stock for a total purchase price of $8.8 million. The shares acquired in each of these transactions were recorded as Treasury stock upon repurchase. There were no share repurchases during the three and six months ended June 30, 2021.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration